Results 221 to 230 of about 18,044 (238)

Biosimilars

International Journal of Pharmaceutical Medicine, 2007
Schellekens, H., Jiskoot, W., Crommelin, D.J.A.   +2 more
openaire   +3 more sources

Efficacy of infliximab biosimilars in patients with Crohn's disease

Lancet, The, 2017
Davide G Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano   +2 more
exaly  

Biosimilars.

PDA journal of pharmaceutical science and technology, 2016
  +5 more sources

Biosimilars in IBD: from theory to practice

Nature Reviews Gastroenterology and Hepatology, 2016
Silvio Danese, Stefanos Bonovas, Laurent Peyrin-Biroulet   +2 more
exaly  

Biosimilarity

2018
openaire   +2 more sources

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Journal of Clinical Oncology, 2018
Gary H Lyman, Robert Donald Harvey, Richard L Schilsky   +2 more
exaly  

Biosimilars: a new era in access to breast cancer treatment

Lancet, The, 2020
exaly  

Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice

Pharmacological Research, 2017
Cristina Scavone, Concetta Rafaniello, Liberato Berrino   +2 more
exaly  

Monoclonal antibody biosimilars

Nature Reviews Drug Discovery, 2015
exaly  

Biosimilars in rheumatology: current perspectives and lessons learnt

Nature Reviews Rheumatology, 2015
Thomas Dörner, Jonathan Kay
exaly